By studying the relationship between SMADs family and CRC, in clinical practice, patients with high expression of SMAD1 and SMAD2 and low expression of SMAD3, SMAD4, and SMAD5 in tissue specimens can be identified as CRC, which can be used as diagnostic markers. This evidence concerns the gene SMAD3 and colorectal carcinoma.